LightNews LightNews
banner
mariamabutair.bsky.social
@mariamabutair.bsky.social
31 followers 89 following 2 posts
❤️ for nephrology, internal medicine, icu! 📚🎼🎹🧳🚵‍♀️🎿🥾
Posts Replies Media Videos
Reposted
jama.com
Continuous glucose monitoring (CGM) enables real-time assessment of glucose trends in individuals with type 2 #diabetes, complementing or replacing fingerstick and HbA1c monitoring.

💡 This JAMA Insights discusses CGM use for type 2 diabetes.

ja.ma/4ogw8xz
JAMA Insights: Continuous Glucose Monitoring, published November 24, 2025. The image shows glucose monitoring data, including time in ranges, glucose metrics, ambulatory glucose profile (AGP), and daily glucose profiles.
November 24, 2025 at 5:00 PM
Reposted
nephroseeker.medsky.social
Probably #nephsky will never see a trial comparing spironolactone with finerenone

Target emulated trial: potential benefits of finerenone in all sorts of outcomes, but we’re comparing 🔝methodology trials (FIGARO, FIDELIO) vs invetigator initiated trials

pubmed.ncbi.nlm.nih.gov/41173939/
November 25, 2025 at 11:38 AM
Reposted
ndt-era.bsky.social
Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents

doi.org/10.1093/ndt/...
Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents
Abstract. Anticancer therapies have significantly improved survival rates in patients with cancer; however, despite prophylactic measures, many conventiona
doi.org
November 25, 2025 at 1:34 PM
Reposted
hswapnil.medsky.social
From @carolyntan.bsky.social

This is a work of art

Have to agree that amlodipine and gabapentin/pregabalin often lead to heart failure misdiagnosis

#MedSky #PharmSky

h/t @davidjuurlink.bsky.social and @jbrianbyrd.bsky.social
Description of a prescription cascade, when an initial prescription for pregabalin or amlodipine causes leg oedema leading to addition of furosemide which causes urinary incontinence. This leads to a RX for Solifenacin which causes cognitive decline and a prescription for Don Pascale. The subsequent anorexia and an insomnia leads to mirtazapine prescription and a hip fracture from a fall. This of course leads to many other cascades, including delirium, haloperidol and levodopa, risedronate, and pantoprazole, or iron and constipation with peg.
November 4, 2025 at 11:31 PM
Reposted
nephrointberlin.bsky.social
It was a pleasure organizing our 5th course on Intensive Care Nephrology together with Nicole Bethke, Martin Kuhlmann and the Akademie Niere. Inspiring lectures and an outstanding group of participants! #nephsky #nephrology
October 16, 2025 at 6:40 AM
Reposted
asnpublications.bsky.social
In three trials, finerenone reduced a range of cardiovascular and kidney outcomes in persons with diabetes and CKD.

Read more in #ASNJASN: kidney.pub/JASN0823

October 8, 2025 at 3:00 PM
Reposted
dgfn.bsky.social
More precise diagnoses, a new guideline and targeted therapies: Glomerulonephritis care is changing. Key topic at the DGfN Annual Meeting 2025 in Berlin.
Read more👉 bit.ly/4pwUxkc

#Nephrology #CKD
Graphic for the Nephrology 2025 annual meeting of the German Society of Nephrology. Text: ‘Progress in glomerulonephritis: more precise diagnoses, targeted innovative therapies and new guideline improve care.’ Below: ‘Nephrology 2025 – 17th Annual Meeting of the DGfN, October 2–5, 2025, Estrel Congress Center Berlin.’ Design in blue and green tones with logo.
September 25, 2025 at 12:31 PM
Reposted
markusathome.bsky.social
It's Congress-Update time!
Check out our new webinar "Post ESC 2025"!

youtu.be/6C6lJWUHlc8?...
Post ESC 2025
YouTube video by MARKUS at HOMe
youtu.be
September 5, 2025 at 5:57 PM
Reposted
hswapnil.medsky.social
How common is kidney failure with MCD and FSGS?

More than we think … @brianrifkin.bsky.social breaks down the recent @asnpublications.bsky.social JASN paper from the RaDaR study www.nephjc.com/news/nephjc-...
Visual abstract
September 5, 2025 at 8:30 PM
Reposted
thelancetendo.bsky.social
We propose that drug-induced weight loss is largely responsible for the reported improvements in osteoarthritis, obstructive sleep apnoea, and metabolic dysfunction-associated steatohepatitis outcomes www.thelancet.com/journals/lan...
#weightloss #GLP-1 receptor agonists

#MedSky #EndoSky#LiverSky
Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions
The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct effects of these drugs is the subject of intense interest. Although reductions in...
www.thelancet.com
August 24, 2025 at 9:31 AM
Reposted
hswapnil.medsky.social
Spironolactone does not work for dialysis

ACHIEVE published in @thelancet.com

@lastwalsh.bsky.social and colleagues

www.thelancet.com/journals/lan...

Coming soon to a #NephJC near you
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial
Among patients receiving maintenance dialysis, spironolactone 25 mg daily orally did not reduce the composite outcome of cardiovascular mortality and hospitalisation due to heart failure compared with...
www.thelancet.com
August 14, 2025 at 11:15 PM
Reposted
asnpublications.bsky.social
Peritoneal dialysis (PD) is not often used for patients with Autosomal dominant polycystic kidney disease (ADPKD). This #ASNKidney360 research demonstrates that PD is safe and effective for patients with ADPKD. Read more: kidney.pub/KID0888
July 29, 2025 at 5:00 PM
Reposted
natrevneph.nature.com
ICYMI:
Pregnancy-associated acute kidney injury — consensus report of the 32nd Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology, Published online: 18 July 2025; doi:10.1038/s41581-025-00979-6Pregnancy-associated acute kidney injury is a risk factor for maternal and fetal morbidity and mortality and a driver of health inequity worldwide. This Consensus Statement from the Acute Disease Quality Initiative provides recommendations on the causes, diagnosis, management and follow-up of pregnancy-associated acute kidney injury.
www.nature.com
July 24, 2025 at 12:31 AM
Reposted
criticalcarereviews.com
Expanding the boundaries of kidney replacement therapy in patients with liver failure

CCR Journal Watch - tracking the critical care literature daily
https://criticalcarereviews.com/latest-evidence/journal-watch
July 21, 2025 at 4:17 PM
Reposted
nejm.org
In the PREDMETH trial, first-line treatment of pulmonary sarcoidosis with methotrexate was noninferior to that with prednisone regarding the change at 24 weeks in the percentage of the predicted forced vital capacity. Full trial results and Research Summary: nej.md/4kdaf0o

#MedSky #PulmSky
The New England Journal of Medicine Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate A Research Summary based on Kahlmann V et al. | 10.1056/NEJMoa2501443 | Published on May 18, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
July 21, 2025 at 5:03 PM
Reposted
natrevneph.nature.com
Pregnancy-associated acute kidney injury — consensus report of the 32nd Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology, Published online: 18 July 2025; doi:10.1038/s41581-025-00979-6Pregnancy-associated acute kidney injury is a risk factor for maternal and fetal morbidity and mortality and a driver of health inequity worldwide. This Consensus Statement from the Acute Disease Quality Initiative provides recommendations on the causes, diagnosis, management and follow-up of pregnancy-associated acute kidney injury.
www.nature.com
July 18, 2025 at 12:30 PM
Reposted
theisn.org
A new conceptual review for Secondary Membranous Nephropathy
Always think broader when the puzzle doesn’t fit perfectly.
#ECNeph @dramiliflores.bsky.social @karnephro.bsky.social
www.emjreviews.com/w...
June 30, 2025 at 4:23 PM
Reposted
criticalcarereviews.com
Today's Paper of the Day is:

Demystifying Volume Status. An Ultrasound-Guided Physiologic Framework.

https://criticalcarereviews.com/latest-evidence/paper-of-the-day

Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2025
June 29, 2025 at 9:41 AM
Reposted
thelancetendo.bsky.social
By re-evaluating current definitions, acknowledging the progressive nature of type 2 #diabetes, and embracing individualised approaches to glycaemic control, #remission can be redefined as a dynamic continuum rather than a static endpoint www.thelancet.com/journals/lan... #T2D

#MedSky #EndoSky
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches
Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and feasibility of remission warrant closer examination. Type 2 diabetes remissio...
www.thelancet.com
June 29, 2025 at 10:00 AM
Reposted
gunnarheine.bsky.social
Best of ERA 25 @markusathome.bsky.social with
@lonniepyne.bsky.social @lastwalsh.bsky.social
Dr. Stel Dr. Staplin Dr. Mann Dr. Fakhouri
@rosertorra.bsky.social @katestevens.bsky.social @marcussaemann.bsky.social @sarahelena.bsky.social
@dgfn.bsky.social @sfndt.bsky.social
youtu.be/HbUEh8oLB2M?...
62nd ERA Congress - Profs. L. Pyne, F. Fakhouri, M. Walsh, H. Mann, N. Staplin, V. Stel & J. Barratt
YouTube video by MARKUS at HOMe
youtu.be
June 13, 2025 at 11:48 AM
Reposted
dgfn.bsky.social
Post-ERA 2025 webinar on 13 June at 7:15 pm! Late-Breaker on kidney diseases in focus - with top researchers, including on IgAN, C3G, MRA & transplantation. Make a note now!
👉MARKUS at HOMe: www.youtube.com/watch?v=Q6WP...
Post ERA 2025 - NDT / MARKUS at HOMe Special
YouTube video by MARKUS at HOMe
www.youtube.com
June 5, 2025 at 8:24 AM
Reposted
gunnarheine.bsky.social
youtu.be/s-iglqVIp2s?...

With @marcussaemann.bsky.social @sarahelena.bsky.social @rosertorra.bsky.social Prof. Anders Prof. Stevens
Post ERA 2025 - NDT / MARKUS at HOMe Special
YouTube video by MARKUS at HOMe
youtu.be
June 9, 2025 at 8:33 AM
Reposted
runningkidneys.bsky.social
In the CONFIDENCE trial, combo therapy with #finerenone + #empagliflozin led to a >50% reduction in albuminuria over 180 days in patients with #CKD & #T2D — significantly greater than either drug alone. Safe, effective, synergistic.
👉 www.nejm.org/doi/full/10....
https://www.nejm.org/doi/full/10.1056/NEJMoa2410659
www.nejm.org
June 5, 2025 at 12:05 PM
Reposted
runningkidneys.bsky.social
🔍 New meta-analysis of 1.8M+ patients shows even mild or short-duration AKI significantly increases risk of CKD, kidney failure & MAKE.
➡️ AKI stage 1: HR 1.49 for CKD
➡️ AKI <3 days: OR 2.37 for CKD
📢 Time to prioritize post-AKI kidney protection!

doi.org/10.1093/ndt/...
June 5, 2025 at 12:16 PM
Reposted
markusathome.bsky.social
It's time for a new update on kidney transplantation with Prof. Böhmig!

youtu.be/qlgBwc6g4rQ?...
Update Nierentransplantation 2025 - Prof. Dr. Georg Böhmig (Wien, Österreich)
YouTube video by MARKUS at HOMe
youtu.be
May 30, 2025 at 7:10 PM